Search Results 241-250 of 16067 for pharmacogenetics
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Rochester, Minn. The purpose of this study is to understanding the mechanisms of weight gain in patients following liver transplantation, action, and indicate ...
This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...
Hereditary BRCA-related breast and ovarian cancer, Lynch syndrome and familial hypercholesterolemia are estimated to be relatively prevalent in the general ...
Learn about available training opportunities in the Genetics of Liver Disease Lab led by Kirk J. Wangensteen, M.D., Ph.D., at Mayo Clinic's campus in ...
LQTS is a genetic heart disease that can potentially cause fast, chaotic heartbeats. These rapid heartbeats might trigger people to faint suddenly. Some people ...
About this study. The objectives of this protocol are to develop and validate clinical assays for inborn errors of metabolism (IEMs) using specimens ...
p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. Pharmacogenetics. 1998 Dec; 8(6): ...
About this study. The purpose of this investigation is to develop and maintain a database for patients with PD +/- ED in the five years preceding the ...
Research. Mayo Clinic researchers have a rich history in advancing precision medicine for breast cancer. Projects include: Finding new therapies for breast ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.